drugset / Trial / NCT01296087
TC-6987 for the Treatment of Mild to Moderate Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to determine whether TC-6987 improves respiratory function in subjects with asthma by reducing airway hyper-responsiveness and inflammation.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TC-6987 | Small molecule | 50 mg | — |